NCT02133105View on ClinicalTrials.gov

Levosimendan Versus Dobutamine for Renal Function in Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Cardiorenal Syndrome
Interventions
DRUG

Levosimendan

DRUG

Dobutamine

Trial Locations (1)

41345

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

lead

Göteborg University

OTHER

NCT02133105 - Levosimendan Versus Dobutamine for Renal Function in Heart Failure | Biotech Hunter | Biotech Hunter